Just a few days after General Motors (NYSE: GM) broke the news that it was ending its endorsement deal with Tiger Woods, NBA phenom LeBron James' agent told reporters that Microsoft (NASDAQ: MSFT) would not be renewing its two-year old marketing deal with the Cleveland Cavaliers forward.
King James, as he is known, appeared in commercials for the Windows Vista operating system, but very little else came of the partnership. According to The Associated Press, "The partnership faltered when Microsoft executive Joanne Bradford, who struck the deal with James, resigned as head of the company's media network this year."
These celebrity endorsement deals attract little attention from investors when times are good, but with most companies faltering now, they seem to be attracting more ire. James' seven-year, $90 million deal with Nike (NYSE: NKE) makes sense: LeBron James is a powerful force in selling basketball shoes. The terms of the Microsoft deal were not disclosed, but it seems unlikely that James contributed to any increase in sales of Microsoft products -- would anyone choose their operating system based on a basketball player in a commercial?
I can't help but question the motives behind these kinds of endorsement deals: are they inspired by a desire to drive sales and create shareholder value or a desire to hobnob with celebrities?
Last updated: February 09, 2012: 08:49 PM
Hot Stocks
DailyFinance Headlines
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
Benzinga Headlines
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
- Vodafone Misses Quarterly Revenue
TheFlyOnTheWall.com Headlines
- Zumiez relocating ecommerce operations to Kansas
- AbitibiBowater announces termination of Fibrek's Shareholder Rights Plan
- Rockwell Medical 1.845M share registered direct offering priced at $9.50
- Activision Blizzard says Skylanders has potential to be next $1B franchise
- Activision Blizzard expects expanding non-GAAP margins in FY12
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal

